3 Result(s)
within
John J. Park
Biomedicine
-
Article
Open AccessEfficacy of anti-PD-1 therapy in patients with melanoma brain metastases
There is limited data on the efficacy of anti-programmed death 1 (PD-1) antibodies in patients (pts) with melanoma brain metastasis (BM), particularly those which are symptomatic.
-
Article
Open AccessProtein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling
Uveal melanoma (UM) is a rare cancer arising from melanocytes in the uveal tract of the eye. Despite effective primary treatment, there is no approved therapy for metastatic UM and prognosis and survival remai...
-
Article
Open AccessA first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
We assessed nofazinlimab, an anti-PD-1 antibody, in solid tumors and combined with regorafenib in metastatic colorectal cancer (mCRC).
